Description

Cinchophen (CAS 132-60-5), also known as 2-phenylquinoline-4-carboxylic acid, is a quinoline derivative with the molecular formula C₁₆H₁₁NO₂. This high-purity compound is a valuable research chemical, commonly utilized in biochemical and pharmacological studies. Its crystalline structure and well-defined properties make it ideal for analytical applications, including HPLC, LC-MS, and spectroscopy. Cinchophen is supplied as a fine powder with ≥98% purity, ensuring consistency for laboratory use. Proper storage in a cool, dry environment is recommended to maintain stability. Suitable for researchers investigating anti-inflammatory, analgesic, or uricosuric mechanisms.

Properties

• CAS Number: 132-60-5
• Complexity: 325
• IUPAC Name: 2-phenylquinoline-4-carboxylic acid
• InChI: InChI=1S/C16H11NO2/c18-16(19)13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H,(H,18,19)
• InChI Key: YTRMTPPVNRALON-UHFFFAOYSA-N
• Exact Mass: 249.078978594
• Molecular Formula: C16H11NO2
• Molecular Weight: 249.26
• SMILES: C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O
• Topological: 50.2
• Monoisotopic Mass: 249.078978594
• Color/Form: NEEDLES FROM METHANOL OR DILUTED ALCOHOL
• Odor: ODORLESS
• Taste: SLIGHTLY BITTER TASTE
• Melting Point: 218 °C
• Solubility: RAPIDLY LOSES WATER OF CRYSTALLIZATION ON EXPOSURE TO AIR; SOL IN WATER, ALC; PRACTICALLY INSOL IN ETHER /LITHIUM SALT OCTAHYDRATE/
• Stability/Shelf Life: STABLE TO AIR, BUT TURNS YELLOW UNDER THE INFLUENCE OF LIGHT
• Refractive Index: INDEX OF REFRACTION IN ORTHORHOMBIC SYSTEM: 1.545 , 1.575 , EXCEEDS 1.734 ; INDEX OF REFRACTION IN TRICLINIC SYSTEM: 1.545 , 1.590 , 1.630 ; INDEX OF REFRACTION IN TRICLINIC SYSTEM: 1.545 , 1.590 , 1.630
• Synonyms: Cinchophen, 2-Phenylquinoline-4-carboxylic acid, 2-Phenyl-4-quinolinecarboxylic acid, Cinchopen, 2-Phenylcinchoninic acid, Cinchophene, Atophan, Tervalon, Cinconal, Phenoquin, Quinofen, Quinophan, Quinophen, Atofan, Cinchophenic acid, Aciphenochinolinium, Aminophan, Cincosal, Ikterosan, Mylofanol, Phenophan, Rhematan, Tophosan, Traubofan, Agotan, Alutyl, Artexin, Atigoa, Atocin, Rheumin, Tophol, Vantyl, Viophan, Artam, Aciphenochinoline, CINCOPHEN, 2-Phenylcinchonic acid, Acifenokinolin, Cincofeno, Artamin, 4-Quinolinecarboxylic acid, 2-phenyl-, Aciphenochinolinum, Cinchoninic acid, 2-phenyl-, Cincofene [DCIT], Cinchophenum, Cincofene, Phenylcinchoninic Acid, 2-Phenyl-quinoline-4-carboxylic acid, Cincofeno [INN-Spanish], Cinchophene [INN-French], Cinchophenum [INN-Latin], NSC 2617, Rheumatan, Alutyo, HSDB 2085, 2-Phenylquinoline-4-carboxlic acid, NSC-2617, Cinchophen [INN:BAN:NF], EINECS 205-067-1, Cinchophen (BAN), BRN 0192803, DTXSID0040705, UNII-39Y533Z02M, AI3-15400, CINCHOPHEN [MI], CINCHOPHEN [INN], CINCHOPHEN [HSDB], 39Y533Z02M, CINCHOPHEN [MART.], CINCHOPHEN [WHO-DD], N-Cyclohexyl-2-phenyl-4-chinolincarboxamid, DTXCID8020705, 5-22-03-00484 (Beilstein Handbook Reference), 2-Phenylquinolinecarboxylic acid-(4), Cincofeno (INN-Spanish), Cinchophene (INN-French), Cinchophenum (INN-Latin), CINCHOPHEN (MART.), aciphenochinolium, aciphenocholinum, M04AC02, methylium phenylcinchoninicum (for ester), 4-Quinolinecarboxylic acid, 2-phenyl-(9CI), 205-067-1, ytrmtppvnralon-uhfffaoysa-n, 132-60-5, MFCD00006750, MLS000053018, CHEMBL348000, NCGC00018221-06, NCGC00018221-08, SMR000059017, WLN: T66 BNJ CR & EVQ, CAS-132-60-5, SR-01000000141, Cincain (TN), Cinchophen (Standard), 2-Phenylquinoline acid, Opera_ID_819, Cambridge id 5117240, TimTec1_001239, Oprea1_652483, SCHEMBL25519, MLS000069591, MLS001074296, HY-B0972R, NSC2617, CHEBI:114195, HMS1537I07, HMS2236H09, HMS3264N13, HMS3369G13, HMS3652D09, HMS5082J08, Pharmakon1600-01504508, ALBB-035149, HY-B0972, MSK11308, NSC70178, Tox21_110841, Tox21_400022, BBL011719, BDBM50097100, CCG-34161, NSC-70178, NSC758887, SBB000885, STK076256, 2-phenyl-4-quinoline-carboxylic acid, AKOS000264299, Tox21_110841_1, CS-4461, DB13551, FP44219, NSC-758887, SB18446, NCGC00018221-01, NCGC00018221-02, NCGC00018221-03, NCGC00018221-04, NCGC00018221-05, NCGC00018221-07, NCGC00018221-09, NCGC00018221-10, NCGC00018221-13, NCGC00021229-04, NCGC00021229-05, NCGC00021229-06, AS-56238, ST013890, SY048847, 2-Phenyl-4-quinolinecarboxylic acid, 99%, SBI-0207075.P001, DB-000656, EU-0096447, NS00024224, P1301, S4190, SW089640-2, EN300-16799, D07280, D92104, AB00275103-10, AB00275103-16, AB00275103_18, AB00275103_19, AE-641/00678051, Q5120196, SR-01000000141-2, SR-01000000141-4, BRD-K72915123-001-01-7, BRD-K72915123-001-11-6, BRD-K72915123-001-17-3, BRD-K72915123-001-18-1, Z56782585, F0391-0013

Application

Cinchophen has been historically studied for its uricosuric and anti-inflammatory properties, making it relevant for research on gout and metabolic disorders. It serves as a model compound in pharmacological studies exploring quinoline derivatives. Researchers also investigate its potential interactions with proteins and enzymes in biochemical pathways. Its structural features make it useful as a building block in synthetic organic chemistry.

Safety and Hazards

GHS Hazard Statements

• H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

Precautionary Statements

• P264, P270, P301+P317, P330, and P501

Hazard Classes and Categories

• Acute Tox. 4 (100%)

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.